|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| Net revenue | |||||
| Sleep and Respiratory Care | |||||
| Software as a Service | |||||
| Sleep and Breathing Health | |||||
| Residential Care Software | |||||
| Total net revenue | |||||
| Cost of sales (exclusive of amortization shown separately below) | |||||
| Sleep and Respiratory Care | |||||
| Software as a Service | |||||
| Sleep and Breathing Health | |||||
| Residential Care Software | |||||
| Total cost of sales (exclusive of amortization shown separately below) | |||||
| Amortization of acquired intangible assets | |||||
| Sleep and Respiratory Care | |||||
| Software as a Service | |||||
| Sleep and Breathing Health | |||||
| Residential Care Software | |||||
| Total amortization of acquired intangible assets | |||||
| Total cost of sales | |||||
| Gross profit | |||||
| Operating Expenses | |||||
| Research and development | |||||
| Selling, general, and administrative | |||||
| Amortization of acquired intangible assets | |||||
| Restructuring expenses (note 17) | |||||
| Acquisition related expenses | |||||
| Total operating expenses | |||||
| Income from operations | |||||
| Other income (loss), net: | |||||
| Interest income (expense), net | |||||
| Gain (loss) attributable to equity method investments (note 6) | |||||
| Gain (loss) on equity investments (note 6) | |||||
| Gain on insurance recoveries | |||||
| Other, net | |||||
| Total other income (loss), net | |||||
| Income before income taxes | |||||
| Income taxes (note 12) | |||||
| Net income | |||||
| Basic earnings per share (note 11) (in dollars per share) | |||||
| Diluted earnings per share (note 11) (in dollars per share) | |||||
| Dividend declared per share (in dollars per share) | |||||
| Basic shares outstanding (000's) (in shares) | |||||
| Diluted shares outstanding (000's) (in shares) | |||||
Loading...